Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

37.5%

3 terminated/withdrawn out of 8 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07440056Not ApplicableNot Yet Recruiting

Physical Inactivity Among Patients With Cardiovascular Risk

Role: lead

NCT06838559Phase 4Active Not Recruiting

Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks vs. 14-day and no Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS)

Role: lead

NCT06726317Not ApplicableCompleted

Early Palliative Care for Patients with Oral Cancer in Sri Lanka

Role: lead

NCT03922594Terminated

Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia

Role: collaborator

NCT02388542Not ApplicableUnknown

Effect of Peer-mentor Mediated Interventions on Cardiovascular Risk Factors at Worksites

Role: collaborator

NCT02274948Phase 4Completed

Use of Metformin in Treatment of Childhood Obesity

Role: lead

NCT02893280Withdrawn

Acute Coronary Syndrome Sri Lanka Audit Project

Role: lead

NCT01668472Withdrawn

A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes

Role: lead

All 8 trials loaded